| |
 |
|
Class Information
Number: 540/2
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium or tellurium) or nitrogen as the only ring hetero atoms > Cyclopentanohydrophenanthrene ring system containing
Description:
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7405206 |
Anti-inflammatory androstane derivatives |
Jul. 29, 2008 |
| 7405207 |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
Jul. 29, 2008 |
| 7381566 |
Method for preparing organic nanotubules of lithocholic acid, nanotubules derived therefrom, and uses thereof |
Jun. 3, 2008 |
| 7229980 |
Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or derivative thereof |
Jun. 12, 2007 |
| 7041839 |
Steroidal antiestrogens and antiandrogens and uses thereof |
May. 9, 2006 |
| 6921757 |
Organic compounds |
Jul. 26, 2005 |
| 6670348 |
Methods and compositions for destruction of selected proteins |
Dec. 30, 2003 |
| 6660725 |
Method and composition for modulating amyloidosis |
Dec. 9, 2003 |
| 6596885 |
19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
Jul. 22, 2003 |
| 6479063 |
Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis |
Nov. 12, 2002 |
| 6417365 |
Method for recovering medicaments from preparations, and from the precursors or wastes thereof |
Jul. 9, 2002 |
| 6369247 |
Process for oxidation of steroidal compounds having allylic groups |
Apr. 9, 2002 |
| 6359113 |
Protective group, compound protected by said group and device for grafting the protective group on the compound to protect it |
Mar. 19, 2002 |
| 6200965 |
17-Azolyl steroids useful as androgren synthesis inhibitors |
Mar. 13, 2001 |
| 5990078 |
Means of increasing estrogen receptor levels in neural tissue |
Nov. 23, 1999 |
| 5962667 |
Pharmaco-gene delivery in human breast cancer cells |
Oct. 5, 1999 |
| 5948925 |
Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids |
Sep. 7, 1999 |
| 5869605 |
Protected compound comprising a protective group removably attached to a compound to be protected |
Feb. 9, 1999 |
| 5869652 |
Process for producing active substances from unused or discarded devices for the transdermal administration |
Feb. 9, 1999 |
| 5843670 |
Carbodiimide group-containing digoxigenin derivatives |
Dec. 1, 1998 |
| 5843933 |
11.beta.-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
Dec. 1, 1998 |
| 5824670 |
17-deoxycorticosteroid-21-[O]carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
Oct. 20, 1998 |
| 5760025 |
Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
Jun. 2, 1998 |
| 5578726 |
Process for producing 7 .beta.-substituted-4-aza-5 .alpha.-androstan-3-ones |
Nov. 26, 1996 |
| 5420120 |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use |
May. 30, 1995 |
| 5397563 |
Perfluoro-t-butyl-containing steroids for use in fluorine-19 NMR and/or MRI |
Mar. 14, 1995 |
| 5278296 |
Production of hydroxysteryl glycoside compounds |
Jan. 11, 1994 |
| 5241070 |
Nucleophilic polysubstituted aryl acridinium esters and uses thereof |
Aug. 31, 1993 |
| 5237064 |
Process for producing 7.beta.-substituted-aza-5.alpha.androstan-3-ones |
Aug. 17, 1993 |
| 5087710 |
Homogeneous rhenium catalysts for metathesis of olefins |
Feb. 11, 1992 |
| 5068226 |
Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies |
Nov. 26, 1991 |
| 4701542 |
Resolution of hemiacetals and alcohols |
Oct. 20, 1987 |
| 3989711 |
Soft quaternary surface active agents exhibiting antibacterial activity |
Nov. 2, 1976 |
|
|
|
